Cutaneous Lupus Erythematosus Cutaneous manifestations occur in up to 80% of patients with lupus. Cutaneous LE may occur with SLE or independently, and can be seronegative for ANAs in the latter case.

EXTON, Pa., Dec. 21, 2010 /PRNewswire/ -- BioTrends Research Group, Inc. is pleased to announce the publication of a new syndicated report focused on the management and treatment of systemic lupus ...

This means that different immune cells and pathogenic mechanisms are at play in patients with SLE and diverse clinical manifestations. This variability makes it difficult to develop one-size-fits ...

SLE is a heterogeneous disease, which can cause many different manifestations and symptoms, and traditionally did not have many treatment options. However, the picture is changing, and clinical ...

For most manifestations, prednisone at 0.25–0.5 mg/kg body weight (or equivalent) is sufficient to obtain good disease control within a few days to weeks.

In the Phase IIa clinical study in SLE patients completed in the US, KPG-818 was well tolerated and demonstrated promising preliminary efficacy in SLE patients with cutaneous manifestations.

Clinical Features and Diagnosis of Late-onset SLE Of interest, the clinical manifestations of late-onset SLE have been found to be comparable in patients with late-onset disease, independent of ...